CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Panacea Global Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Panacea Global Inc
330 Highway 7 East
Suite 502
Phone: (905) 881-1049p:905 881-1049 Richmond Hill, ON  L4B 3P8  Canada Fax: (905) 881-2241f:905 881-2241
This company is no longer actively traded on any major stock exchange.
Business Summary
Panacea Global, Inc. is a biotechnology company focusing on developing and commercializing products for the early detection, diagnosis and monitoring the recurrence of cancer. The Company's product is a blood test that can measure the blood level of Human Aspartyl (Asparaginyl) B-Hydroxylase (HAAH). Its HAAH (a cancer biomarker) is an enzyme, which is over expressed in cancer cells. This test is recommended for men and women over 50 years of age with a history of smoking cigarettes. Its HAAH Blood Test can help the early diagnosis of prostate cancer. Its HAAH Blood Test provides the physician with additional information about the likelihood that a man with an abnormally high prostate-specific antigen (PSA) value, with or without an abnormal digital rectal examination (DRE), may have prostate cancer. Its HAAH Blood Test provides information to differentiate prostate cancer from benign conditions and to help guide patient management.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/201412/31/2013YesYes---

Industries
SIC Code Description
6531 Real estate agents and managers
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Interim Chief Executive Officer, Director YuriLawryshyn 50 6/17/2016 6/15/2016
Interim Chief Financial Officer DavidSohi 6/17/2016 6/17/2016
Chief Operating Officer ArasAzadian 6/17/2016 6/17/2016
Director Chandra J.Panchal 67 6/15/2016 6/15/2016
Director RezaSamimi 2/3/2015 2/3/2015

Business Names
Business Name
HomeLife, Inc.
Panacea Global, Inc.
PANG

General Information
Number of Employees: 3 (As of 12/31/2013)
Outstanding Shares: 106,747,586 (As of 11/14/2014)
Shareholders: 1,061
Stock Exchange: OTC
Federal Tax Id: 330680443
Fax Number: (905) 881-2241


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023